|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 701 to 800 out of 853 for Tgm2

0.021s
Type Details Score
GXD Expression  
Probe: MGI:6715070
Assay Type: Immunohistochemistry
Annotation Date: 2021-06-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1881227
Pattern: Regionally restricted
Stage: TS27
Assay Id: MGI:6715074
Age: postnatal day 3
Note: Expression continuous until postnatal day 3.
Specimen Label: 1e1
Detected: true
Specimen Num: 5
GXD Expression  
Probe: MGI:6715070
Assay Type: Immunohistochemistry
Annotation Date: 2021-06-10
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1881228
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:6715074
Age: postnatal day 7
Note: Expression reduced until postnatal day 7.
Specimen Label: 1f1
Detected: true
Specimen Num: 6
GXD Expression  
Probe: MGI:6715070
Assay Type: Immunohistochemistry
Annotation Date: 2021-06-10
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1881228
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:6715074
Age: postnatal week 3
Note: Expression remained weak in week 3.
Specimen Label: 1g1
Detected: true
Specimen Num: 7
GXD Expression  
Probe: MGI:6715072
Assay Type: RNA in situ
Annotation Date: 2021-06-10
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1881227
Pattern: Regionally restricted
Stage: TS27
Assay Id: MGI:6715076
Age: postnatal day 1
Note: Strong expression in myoepitheilal cells.
Specimen Label: 2e
Detected: true
Specimen Num: 5
GXD Expression  
Probe: MGI:6715072
Assay Type: RNA in situ
Annotation Date: 2021-06-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1881227
Pattern: Regionally restricted
Stage: TS27
Assay Id: MGI:6715076
Age: postnatal day 3
Note: Expression in myoepithelial cells significantly reduced.
Specimen Label: 2f
Detected: true
Specimen Num: 6
GXD Expression  
Probe: MGI:6715072
Assay Type: RNA in situ
Annotation Date: 2021-06-10
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1881228
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:6715076
Age: postnatal day 5
Note: Weak, sparcely localized expression in myoepithellial cells.
Specimen Label: 2g
Detected: true
Specimen Num: 7
GXD Expression  
Probe: MGI:6715072
Assay Type: RNA in situ
Annotation Date: 2021-06-10
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1881228
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:6715076
Age: postnatal day 7
Note: Weak, sparcely localized expression in myoepithellial cells.
Specimen Label: 2h
Detected: true
Specimen Num: 8
GXD Expression  
Probe: MGI:6715072
Assay Type: RNA in situ
Annotation Date: 2021-06-10
Strength: Trace
Sex: Not Specified
Emaps: EMAPS:1881228
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:6715076
Age: postnatal week 3
Note: Minimum expression in myoepithelial cells, almost indistinguishable from control.
Specimen Label: 2i
Detected: true
Specimen Num: 9
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_06
Specimen Label: euxassay_011707_06
Detected: true
Specimen Num: 6
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_07
Specimen Label: euxassay_011707_07
Detected: true
Specimen Num: 7
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_08
Specimen Label: euxassay_011707_08
Detected: true
Specimen Num: 8
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_09
Specimen Label: euxassay_011707_09
Detected: true
Specimen Num: 9
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_10
Specimen Label: euxassay_011707_10
Detected: true
Specimen Num: 10
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_11
Specimen Label: euxassay_011707_11
Detected: true
Specimen Num: 11
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_12
Specimen Label: euxassay_011707_12
Detected: true
Specimen Num: 12
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_13
Specimen Label: euxassay_011707_13
Detected: true
Specimen Num: 13
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_14
Specimen Label: euxassay_011707_14
Detected: true
Specimen Num: 14
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_15
Specimen Label: euxassay_011707_15
Detected: true
Specimen Num: 15
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_16
Specimen Label: euxassay_011707_16
Detected: true
Specimen Num: 16
GXD Expression  
Probe: MGI:3821278
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1625523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4828685
Age: embryonic day 14.5
Image: euxassay_011707_17
Specimen Label: euxassay_011707_17
Detected: true
Specimen Num: 17
GXD Expression    
Probe: MGI:7493915
Assay Type: Immunohistochemistry
Annotation Date: 2023-06-29
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3669527
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:7493920
Age: postnatal newborn
Specimen Label: 4B Neonate
Detected: true
Specimen Num: 14
GXD Expression    
Probe: MGI:7493915
Assay Type: Immunohistochemistry
Annotation Date: 2023-06-29
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3669526
Pattern: Not Specified
Stage: TS26
Assay Id: MGI:7493920
Age: embryonic day 18.5
Specimen Label: 4B E18.5
Detected: true
Specimen Num: 15
GXD Expression    
Probe: MGI:7493915
Assay Type: Immunohistochemistry
Annotation Date: 2023-06-29
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3669524
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:7493920
Age: embryonic day 16.5
Specimen Label: 4B E16.5
Detected: true
Specimen Num: 16
GXD Expression    
Probe: MGI:7493915
Assay Type: Immunohistochemistry
Annotation Date: 2023-06-29
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3768122
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:7493920
Age: embryonic day 14.5
Specimen Label: 2C E14.5
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:7493915
Assay Type: Immunohistochemistry
Annotation Date: 2023-06-29
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3768124
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:7493920
Age: embryonic day 16.5
Specimen Label: 2C E16.5
Detected: true
Specimen Num: 6
GXD Expression    
Probe: MGI:7493915
Assay Type: Immunohistochemistry
Annotation Date: 2023-06-29
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3768126
Pattern: Not Specified
Stage: TS26
Assay Id: MGI:7493920
Age: embryonic day 18.5
Specimen Label: 2C E18.5
Detected: true
Specimen Num: 7
GXD Expression    
Probe: MGI:7493915
Assay Type: Immunohistochemistry
Annotation Date: 2023-06-29
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3768127
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:7493920
Age: postnatal newborn
Specimen Label: 2C Neonate
Detected: true
Specimen Num: 8
GXD Expression    
Probe: MGI:7493915
Assay Type: Immunohistochemistry
Annotation Date: 2023-06-29
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3768122
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:7493920
Age: embryonic day 14.5
Specimen Label: S1 E14.5
Detected: true
Specimen Num: 20
GXD Expression    
Probe: MGI:7493915
Assay Type: Immunohistochemistry
Annotation Date: 2023-06-29
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3768124
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:7493920
Age: embryonic day 16.5
Specimen Label: S1 E16.5
Detected: true
Specimen Num: 21
GXD Expression    
Probe: MGI:7493915
Assay Type: Immunohistochemistry
Annotation Date: 2023-06-29
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3768126
Pattern: Not Specified
Stage: TS26
Assay Id: MGI:7493920
Age: embryonic day 18.5
Specimen Label: S1 E18.5
Detected: true
Specimen Num: 22
GXD Expression    
Probe: MGI:7493915
Assay Type: Immunohistochemistry
Annotation Date: 2023-06-29
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3768127
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:7493920
Age: postnatal newborn
Specimen Label: S1 Neonate
Detected: true
Specimen Num: 23
Publication
First Author: Saydak MM
Year: 1992
Journal: FASEB J
Title: Characterization of the mouse tissue transglutaminase gene
Volume: 6
Issue: 1
Pages: A75 (Abstr.)
Publication
First Author: Nagy L
Year: 1996
Journal: J Biol Chem
Title: Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter.
Volume: 271
Issue: 8
Pages: 4355-65
Publication
First Author: Lin HJ
Year: 2002
Journal: J Biol Chem
Title: Localization of the transglutaminase cross-linking site in SVS III, a novel glycoprotein secreted from mouse seminal vesicle.
Volume: 277
Issue: 5
Pages: 3632-9
Publication  
First Author: Zhang J
Year: 2020
Journal: Neuroscience
Title: Transglutaminase 2 Depletion Attenuates α-Synuclein Mediated Toxicity in Mice.
Volume: 441
Pages: 58-64
Publication
First Author: Bailey CD
Year: 2005
Journal: J Neurochem
Title: Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms.
Volume: 92
Issue: 1
Pages: 83-92
Publication
First Author: Kasahara K
Year: 2010
Journal: Blood
Title: Impaired clot retraction in factor XIII A subunit-deficient mice.
Volume: 115
Issue: 6
Pages: 1277-9
Publication
First Author: Johnson KA
Year: 2008
Journal: J Cell Sci
Title: Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation.
Volume: 121
Issue: Pt 13
Pages: 2256-64
Publication
First Author: Szondy Z
Year: 2006
Journal: Cell Death Differ
Title: Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis.
Volume: 13
Issue: 10
Pages: 1827-9
Publication
First Author: Itoh M
Year: 2011
Journal: J Histochem Cytochem
Title: In situ detection of active transglutaminases for keratinocyte type (TGase 1) and tissue type (TGase 2) using fluorescence-labeled highly reactive substrate peptides.
Volume: 59
Issue: 2
Pages: 180-7
Publication
First Author: Itoh M
Year: 2013
Journal: J Histochem Cytochem
Title: Variations in both TG1 and TG2 isozyme-specific in situ activities and protein expressions during mouse embryonic development.
Volume: 61
Issue: 11
Pages: 793-801
Publication
First Author: Basso M
Year: 2012
Journal: J Neurosci
Title: Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation.
Volume: 32
Issue: 19
Pages: 6561-9
Publication
First Author: Nakano Y
Year: 2007
Journal: J Histochem Cytochem
Title: Expression and localization of plasma transglutaminase factor XIIIA in bone.
Volume: 55
Issue: 7
Pages: 675-85
Publication
First Author: Scarpellini A
Year: 2014
Journal: J Am Soc Nephrol
Title: Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.
Volume: 25
Issue: 5
Pages: 1013-27
Publication
First Author: Lee SK
Year: 2005
Journal: Arch Oral Biol
Title: Transglutaminase 2 expression in the salivary myoepithelial cells of mouse embryo.
Volume: 50
Issue: 3
Pages: 301-8
Publication
First Author: Cecil DL
Year: 2008
Journal: J Immunol
Title: Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes.
Volume: 180
Issue: 12
Pages: 8378-85
Publication
First Author: Scarpellini A
Year: 2009
Journal: J Biol Chem
Title: Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.
Volume: 284
Issue: 27
Pages: 18411-23
Publication  
First Author: Suzuki AS
Year: 2020
Journal: Front Immunol
Title: Essential Role for CD30-Transglutaminase 2 Axis in Memory Th1 and Th17 Cell Generation.
Volume: 11
Pages: 1536
Publication
First Author: Plugis NM
Year: 2017
Journal: J Biol Chem
Title: Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine: IMPLICATIONS FOR CELIAC DISEASE.
Volume: 292
Issue: 5
Pages: 2000-2008
Publication
First Author: Malorni W
Year: 2009
Journal: Cell Death Differ
Title: The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis.
Volume: 16
Issue: 11
Pages: 1480-92
Publication
First Author: Holmes FE
Year: 1996
Journal: Neurosci Lett
Title: Superactivation of transglutaminase type 2 without change in enzyme level occurs during progressive neurodegeneration in the mnd mouse mutant.
Volume: 213
Issue: 3
Pages: 185-8
Publication
First Author: Serrano RL
Year: 2019
Journal: PLoS One
Title: A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia.
Volume: 14
Issue: 4
Pages: e0212235
Publication
First Author: Lin CH
Year: 2016
Journal: Kidney Int
Title: Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney.
Volume: 89
Issue: 6
Pages: 1281-92
Publication
First Author: Funsten MC
Year: 2023
Journal: Cell Host Microbe
Title: Microbiota-dependent proteolysis of gluten subverts diet-mediated protection against type 1 diabetes.
Volume: 31
Issue: 2
Pages: 213-227.e9
Publication
First Author: Iadevaia V
Year: 2006
Journal: Cell Death Differ
Title: ATP-binding cassette transporter 1 and transglutaminase 2 act on the same genetic pathway in the apoptotic cell clearance.
Volume: 13
Issue: 11
Pages: 1998-2001
Publication
First Author: Birchenough GMH
Year: 2023
Journal: Cell Rep
Title: Muc2-dependent microbial colonization of the jejunal mucus layer is diet sensitive and confers local resistance to enteric pathogen infection.
Volume: 42
Issue: 2
Pages: 112084
Publication
First Author: Jung SM
Year: 2013
Journal: Am J Physiol Heart Circ Physiol
Title: Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice.
Volume: 305
Issue: 6
Pages: H803-10
Publication
First Author: Menalled LB
Year: 2014
Journal: PLoS One
Title: Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6/2 and zQ175 mouse models of Huntington's disease.
Volume: 9
Issue: 6
Pages: e99520
Publication
First Author: Bhedi CD
Year: 2020
Journal: FASEB J
Title: Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling.
Volume: 34
Issue: 1
Pages: 930-944
Publication  
First Author: Rossin F
Year: 2018
Journal: EMBO Rep
Title: TG2 regulates the heat-shock response by the post-translational modification of HSF1.
Volume: 19
Issue: 7
Publication
First Author: Williams H
Year: 2010
Journal: Atherosclerosis
Title: Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse.
Volume: 210
Issue: 1
Pages: 94-9
Publication
First Author: Johnson KA
Year: 2003
Journal: J Biol Chem
Title: Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy.
Volume: 278
Issue: 21
Pages: 18824-32
Publication  
First Author: Oh K
Year: 2013
Journal: Respir Res
Title: Airway epithelial cells initiate the allergen response through transglutaminase 2 by inducing IL-33 expression and a subsequent Th2 response.
Volume: 14
Pages: 35
Publication
First Author: Wang Y
Year: 2012
Journal: Biochem Biophys Res Commun
Title: Overexpression of phospho mutant forms of transglutaminase 2 downregulates epidermal growth factor receptor.
Volume: 417
Issue: 1
Pages: 251-5
Publication
First Author: Beckouche N
Year: 2015
Journal: Sci Signal
Title: The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis.
Volume: 8
Issue: 385
Pages: ra70
Publication
First Author: Xu L
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.
Volume: 103
Issue: 24
Pages: 9023-8
Publication
First Author: Janiak A
Year: 2006
Journal: Mol Biol Cell
Title: Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway.
Volume: 17
Issue: 4
Pages: 1606-19
Publication
First Author: Liu T
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis.
Volume: 104
Issue: 47
Pages: 18682-7
Publication
First Author: Zemskov EA
Year: 2007
Journal: J Cell Sci
Title: Cell-surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1.
Volume: 120
Issue: Pt 18
Pages: 3188-99
Publication
First Author: Shin DM
Year: 2008
Journal: FASEB J
Title: TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation.
Volume: 22
Issue: 7
Pages: 2498-507
Publication
First Author: Saiki R
Year: 2011
Journal: Biochem Biophys Res Commun
Title: Brain infarction correlates more closely with acrolein than with reactive oxygen species.
Volume: 404
Issue: 4
Pages: 1044-9
Publication
First Author: Papista C
Year: 2012
Journal: Lab Invest
Title: Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics.
Volume: 92
Issue: 4
Pages: 625-35
Publication
First Author: De Laurenzi V
Year: 2001
Journal: Mol Cell Biol
Title: Gene disruption of tissue transglutaminase.
Volume: 21
Issue: 1
Pages: 148-55
Publication    
First Author: Giera S
Year: 2018
Journal: Elife
Title: Microglial transglutaminase-2 drives myelination and myelin repair via GPR56/ADGRG1 in oligodendrocyte precursor cells.
Volume: 7
Publication  
First Author: Cordell PA
Year: 2015
Journal: Matrix Biol
Title: Normal Bone Deposition Occurs in Mice Deficient in Factor XIII-A and Transglutaminase 2.
Volume: 43
Pages: 85-96
Publication
First Author: Mousa A
Year: 2017
Journal: Cell Death Differ
Title: Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
Volume: 24
Issue: 5
Pages: 844-854
Publication
First Author: Tarantino U
Year: 2009
Journal: Amino Acids
Title: FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice.
Volume: 36
Issue: 4
Pages: 679-84
Publication
First Author: Grenard P
Year: 2001
Journal: J Biol Chem
Title: Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z.
Volume: 276
Issue: 35
Pages: 33066-78
Publication
First Author: Robitaille K
Year: 2008
Journal: Cell Death Differ
Title: Calphostin C-induced apoptosis is mediated by a tissue transglutaminase-dependent mechanism involving the DLK/JNK signaling pathway.
Volume: 15
Issue: 9
Pages: 1522-31
Publication
First Author: Miura A
Year: 2013
Journal: J Biol Chem
Title: Pituitary adenylate cyclase-activating polypeptide type 1 receptor (PAC1) gene is suppressed by transglutaminase 2 activation.
Volume: 288
Issue: 45
Pages: 32720-30
Publication  
First Author: Sun H
Year: 2020
Journal: Anal Biochem
Title: Assessment of expression and specific activities of transglutaminases TG1, TG2, and FXIII-A during osteoclastogenesis.
Volume: 591
Pages: 113512
Publication
First Author: Yang L
Year: 2014
Journal: Cancer Res
Title: GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
Volume: 74
Issue: 4
Pages: 1022-31
Publication
First Author: Matsuki M
Year: 1998
Journal: Proc Natl Acad Sci U S A
Title: Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase).
Volume: 95
Issue: 3
Pages: 1044-9
Publication
First Author: Pitolli C
Year: 2017
Journal: Amino Acids
Title: Characterization of TG2 and TG1-TG2 double knock-out mouse epidermis.
Volume: 49
Issue: 3
Pages: 635-642
Publication
First Author: Beazley KE
Year: 2013
Journal: J Biol Chem
Title: Two sides of MGP null arterial disease: chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin.
Volume: 288
Issue: 43
Pages: 31400-8
Publication
First Author: Piredda L
Year: 1997
Journal: Cell Death Differ
Title: Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLIpr/Ipr mice.
Volume: 4
Issue: 6
Pages: 463-72
Publication  
First Author: Wang Y
Year: 2012
Journal: BMC Cancer
Title: Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN.
Volume: 12
Pages: 277
Publication
First Author: D'Eletto M
Year: 2018
Journal: Cell Rep
Title: Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75.
Volume: 25
Issue: 13
Pages: 3573-3581.e4
Publication
First Author: Adel Moallem S
Year: 1996
Journal: Biol Reprod
Title: Transglutaminase and clusterin induction during normal and abnormal limb development in the mouse.
Volume: 55
Issue: 2
Pages: 281-90
Publication
First Author: Verderio E
Year: 1998
Journal: Exp Cell Res
Title: Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death.
Volume: 239
Issue: 1
Pages: 119-38
Publication
First Author: Nakagawa N
Year: 2012
Journal: J Dermatol Sci
Title: Knocking-in the R142C mutation in transglutaminase 1 disrupts the stratum corneum barrier and postnatal survival of mice.
Volume: 65
Issue: 3
Pages: 196-206
Publication
First Author: Nurminskaya M
Year: 2014
Journal: J Vasc Res
Title: Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.
Volume: 51
Issue: 6
Pages: 418-28
Publication
First Author: Delhase M
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2.
Volume: 109
Issue: 4
Pages: E177-86
Publication
First Author: Yu W
Year: 2019
Journal: Lab Invest
Title: Lens-specific conditional knockout of Msx2 in mice leads to ocular anterior segment dysgenesis via activation of a calcium signaling pathway.
Volume: 99
Issue: 11
Pages: 1714-1727
Publication
First Author: Jurisicova A
Year: 1998
Journal: Mol Reprod Dev
Title: Expression and regulation of genes associated with cell death during murine preimplantation embryo development.
Volume: 51
Issue: 3
Pages: 243-53
Publication
First Author: Sauls K
Year: 2012
Journal: Cardiovasc Res
Title: Developmental basis for filamin-A-associated myxomatous mitral valve disease.
Volume: 96
Issue: 1
Pages: 109-19
Publication
First Author: Ortega N
Year: 2005
Journal: Mol Biol Cell
Title: Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation.
Volume: 16
Issue: 6
Pages: 3028-39
Publication    
First Author: Zhou Y
Year: 2022
Journal: Elife
Title: Airway basal cells show regionally distinct potential to undergo metaplastic differentiation.
Volume: 11
Publication
First Author: Schultz NG
Year: 2016
Journal: G3 (Bethesda)
Title: The Genetic Basis of Baculum Size and Shape Variation in Mice.
Volume: 6
Issue: 5
Pages: 1141-51
Publication
First Author: Williams CJ
Year: 1996
Journal: Mol Reprod Dev
Title: G protein gene expression during mouse oocyte growth and maturation, and preimplantation embryo development.
Volume: 44
Issue: 3
Pages: 315-23